fenofibrate has been researched along with Congestive Ophthalmopathy in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, A | 2 |
| Ferrari, SM | 2 |
| Frascerra, S | 2 |
| Ruffilli, I | 2 |
| Gelmini, S | 2 |
| Minuto, M | 1 |
| Pupilli, C | 2 |
| Miccoli, P | 1 |
| Sellari-Franceschini, S | 2 |
| Ferrannini, E | 2 |
| Fallahi, P | 2 |
| Bernini, G | 1 |
2 other studies available for fenofibrate and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes.
Topics: Adipocytes; Chemokine CXCL11; Chemokine CXCL9; Enzyme-Linked Immunosorbent Assay; Eye; Fenofibrate; | 2012 |
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
Topics: Cells, Cultured; Chemokine CCL2; Chemokine CXCL10; Fenofibrate; Fibroblasts; Graves Ophthalmopathy; | 2012 |